Our Impact

Price right case study

How a fast, agile, and robust price triangulation across multiple rare blood disorders supported an asset indication prioritization strategy

IMPACT

  • Inbeeo adopted an agile and robust approach to the research to ensure that the project was completed in 2 working weeks – in time for the client’s portfolio review

  • The pricing calculator developed for the client was used to inform their indication prioritization strategy

Inbeeo's Client

Inbeeo’s client, a large biotech company, was developing a novel monoclonal antibody in the treatment of multiple rare blood disorders. To inform their strategy, they needed a price estimate of their main comparator, intravenous immunoglobulins (IVIG).

THE CHALLENGE

Treatment regimens with IVIG are complex and diverse and involve hospital stays, often making the assessment of their total costs challenging.

HOW WE APPROACHED THE CHALLENGE

Inbeeo developed a price calculator for IVIG treatments in major markets based on:

  • A re-analysis of the initial claims’ dataset

  • A small number of targeted expert interviews

  • List prices of main IVIG brands

  • Insights on hospital rebates